RIO DE JANEIRO, BRAZIL - A first shipment of 88 liters of active ingredients to make Oxford/AstraZeneca’s COVID-19 vaccine in Brazil arrived from China on Saturday, February 6th, essential input to speed the country’s troubled vaccination program.
With those supplies flown into Rio de Janeiro on a cargo plane, the Fiocruz biomedical center can begin filling and finishing 2.8 million doses. The federally funded center expects to receive more ingredients this month to make a total of 15 million shots of the vaccine developed with Oxford University.
The Fiocruz production line, originally scheduled to start producing . . .